Reaching Clinical Recommendations for Intensity of Post-stroke Rehabilitation

Stroke Clinical Trial

Official title:

Reaching Clinical Recommendations for Intensity of Post-stroke Rehabilitation Using an Activity Circuit Implemented With a Change Agent

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04787315
• Other study ID #: CRIR-1423-0719
• Status: Recruiting
• Phase: N/A
• Start date: October 5, 2019
• Est. completion date: September 30, 2023

Study information

• Verified date: June 2022
• Source: Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal
• Contact: Cyril Duclos, PhD
• Phone: 514 343 6111
• Email: cyril.duclos[@]umontreal.ca
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The project aims to implement workstations for mobility training during intensive inpatient rehabilitation to increase the level of motor activity of individuals with hemiparesis due to stroke

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: September 30, 2023
• Est. primary completion date: January 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Receving intensive rehabilitation care for hemiparesis due to stroke in our rehabilitation facility (IRGLM)

Exclusion Criteria:

• Cognitive deficits preventing participation to rehabilitation

Related Conditions & MeSH terms

• Stroke

Intervention

Device:
• Conventional intensive functional rehabilitation + Workstations
Equipment will be provided to participants where they can do exercises to increase their motor abilities at the lower limbs, trunk and upper limbs, in addition to conventional intensive functional rehabilitation

Behavioral:
• Conventional intensive functional rehabilitation
Includes rehabilitation interventions provided by professionnals (OT, PT, speech language therapy, neuropsychologists...)

Locations

Country	Name	City	State
Canada	CIUSSS centre-sud-de-l'ile-de-Montréal	Montréal

Sponsors (1)

Lead Sponsor	Collaborator
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Actimetry	Measure of acceleration data of the paretic lower and upper-limbs by means of an accelerometer (actigraph (r)) placed at the ankle and wrist during seven consecutive days	In the third or fourth week of rehabilitation
Secondary	Gait speed	Measured using the 10-meter walking speed test	Baseline, pre-intensive rehabilitation
Secondary	Balance capacities	Measured using the MiniBESTest or Berg Balance scale according to abilities	Baseline, pre-intensive rehabilitation
Secondary	Gross manual dexterity	Measured using the Box and Block test	Baseline, pre-intensive rehabilitation
Secondary	Gait speed	Measured using the 10-meter walking speed test	End-measure, at the end of rehabilitation
Secondary	Balance capacities	Measured using the MiniBESTest or Berg Balance scale according to abilities	End-measure, at the end of rehabilitation
Secondary	Gross manual dexterity	Measured using the Box and Block test	End-measure, at the end of rehabilitation